Tazorac and Simvastatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazorac (tazarotene) and Simvastatin (simvastatin). Common drug interactions include cholestasis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Tazorac and Simvastatin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tazorac?

Tazorac has active ingredients of tazarotene. It is often used in acne. eHealthMe is studying from 1,046 Tazorac users. Check the latest studies of Tazorac.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.



On Jul, 26, 2026

13 people who take Tazorac and Simvastatin together, and have interactions are studied.

Tazorac and Simvastatin drug interactions.

What are the common drug interactions of Tazorac and Simvastatin, by gender? *:

female:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Back pain
  6. Blood alkaline phosphatase increased
  7. Diarrhoea
  8. Drug ineffective
  9. Eating disorder
  10. Feeling cold

male:

  1. Chronic kidney disease
  2. Allergy to plants
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  7. Drug ineffective
  8. Influenza
  9. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  10. Pneumonia

What are the common drug interactions of Tazorac and Simvastatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal impairment (severely reduced kidney function)
  4. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  2. Back pain
  3. Diarrhoea
  4. Drug ineffective
  5. Eating disorder
  6. Feeling cold
  7. Headache (pain in head)
  8. Hot flush (sudden feelings of heat)
  9. Micturition urgency (urgency to pass the urine)
  10. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

60+:

  1. Allergy to plants
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Viral infection
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Blood alkaline phosphatase increased
  7. Gamma-glutamyltransferase increased
  8. Hepatocellular damage (liver damage)
  9. Hyperbilirubinaemia (excess of bilirubin in the blood)
  10. Influenza

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 3 people, 23.08%
  2. Muscle Spasms (muscle contraction): 3 people, 23.08%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  4. Cardiac Disorder: 3 people, 23.08%
  5. Blood Pressure Abnormal: 3 people, 23.08%
  6. Infection: 3 people, 23.08%
  7. Inflammation: 3 people, 23.08%
  8. Migraine (headache): 3 people, 23.08%
  9. Diabetes: 3 people, 23.08%
  10. Psoriasis (immune-mediated disease that affects the skin): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Tazorac and Simvastatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tazorac and Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tazorac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazorac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tazarotene and simvastatin (the active ingredients of Tazorac and Simvastatin, respectively), and Tazorac and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: